Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Change in Accured Expenses (2024 - 2025)

Historic Change in Accured Expenses for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $1.4 million.

  • Kestra Medical Technologies' Change in Accured Expenses fell 1616.04% to $1.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.4 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2025, which is 114447.44% up from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' Change in Accured Expenses is $1.4 million, which was down 1616.04% from -$860000.0 recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Change in Accured Expenses ranged from a high of $1.9 million in Q2 2025 and a low of -$860000.0 during Q3 2025